Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06094491 · ClinicalTrials.gov registry record · Phase 2
Virtual Diabetes Group Visits Across Health Systems
A Phase 2 study of Obesity and Hypertension, sponsored by University of Chicago.
- Active
- Registry status
- Phase 2
- Development phase
- 720
- Enrollment target
- 2
- Study locations
NCT06094491: Active Phase 2 study of Obesity and Hypertension, sponsored by University of Chicago.
NCT06094491 is a Phase 2 study of Obesity and Hypertension that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 720 participants, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (12% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06094491, a Phase 2 study of Obesity and Hypertension, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 720 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).
Primary Outcome
This is blood test that measures the percent of glucose and hemoglobin bound together.
Conditions Studied
Interventions
- BEHAVIORAL Virtual Group Visit
Study Locations (2)
Illinois
- Access Community Health Network - Chicago
- Advocate Health Care - Orland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 720 participants |
| Start Date | 2024-05-03 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 2 |
What the registry record for NCT06094491 still lists
NCT06094491 is an interventional study that assigns participants to a tested intervention. The registered 720 participants enrollment target is mid-sized for trials with a published cap, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (12% lower).
The record links to 7 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Virtual Group Visit is the first listed.
NCT06094491 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06094491 about?
NCT06094491 is a clinical study titled "Virtual Diabetes Group Visits Across Health Systems". The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).
What is the current status of trial NCT06094491?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 720 participants. The study started on 2024-05-03. Estimated completion is 2026-06-30.
What conditions does trial NCT06094491 study?
This clinical trial studies the following conditions: Obesity, Hypertension, Stroke, Hyperlipidemias, Peripheral Vascular Diseases.
What interventions are being tested in trial NCT06094491?
The interventions under investigation include: Virtual Group Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT06094491?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06094491 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06094491's enrollment target sits among peer trials
720 105th of 1053 higher than 949 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
- NCT05047224 · 720 participants · NA
Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool
- NCT05309395 · 720 participants · Phase 3
Food Prescriptions to Promote Affordable Diets
- NCT05466214 · 720 participants · NA
Systematic Efficacy Replication Study of Conjoint Behavioral Consultation in Elementary Schools
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI